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Alphaviruses and flaviviruses are important human pathogens that include Chikungunya
virus (CHIKV), Dengue virus (DENV), and Zika virus (ZIKV), which can cause diseases
in humans ranging from arthralgia to hemorrhagic fevers and microcephaly. It was
previously shown that treatment with surface layer (S-layer) protein, present on the
bacterial cell-envelope of Lactobacillus acidophilus, is able to inhibit viral and bacterial
infections by blocking the pathogen’s interaction with DC-specific intercellular adhesion
molecule 3-grabbing non-integrin (DC-SIGN), a trans-membrane protein that is a C-type
calcium-dependent lectin. DC-SIGN is known to act as an attachment factor for
several viruses including alphaviruses and flaviviruses. In the present study, we used
alphaviruses as a model system to dissect the mechanism of S-layer inhibition. We
first evaluated the protective effect of S-layer using 3T3 cells, either wild type or stably
expressing DC-SIGN, and infecting with the alphaviruses Semliki Forest virus (SFV)
and CHIKV and the flaviviruses ZIKV and DENV. DC-SIGN expression significantly
enhanced infection by all four viruses. Treatment of the cells with S-layer prior to
infection decreased infectivity of all viruses only in cells expressing DC-SIGN. In vitro
ELISA experiments showed a direct interaction between S-layer and DC-SIGN; however,
confocal microscopy and flow cytometry demonstrated that S-layer binding to the
cells was independent of DC-SIGN expression. S-layer protein prevented SFV binding
and internalization in DC-SIGN-expressing cells but had no effect on virus binding
to DC-SIGN-negative cells. Inhibition of virus binding occurred in a time-dependent
manner, with a significant reduction of infection requiring at least a 30-min pre-incubation
of S-layer with DC-SIGN-expressing cells. These results suggest that S-layer has a
different mechanism of action compared to mannan, a common DC-SIGN-binding
compound that has an immediate effect in blocking viral infection. This difference
could reflect slower kinetics of S-layer binding to the DC-SIGN present at the plasma
membrane (PM). Alternatively, the S-layer/DC-SIGN interaction may trigger the activation
of signaling pathways that are required for the inhibition of viral infection. Together our
results add important information relevant to the potential use of L. acidophilus S-layer
protein as an antiviral therapy.
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INTRODUCTION
Alphaviruses and flaviviruses are medically significant and widely
distributed viral pathogens for which vaccines and antiviral
therapies are urgently needed. Arthritogenic alphaviruses, such
as Chikungunya virus (CHIKV), are mosquito-borne viruses that
cause severe polyarthritis and myositis in humans. Flaviviruses,
such as the emerging pathogen Zika virus (ZIKV) and dengue
virus (DENV), are also transmitted by the same mosquitoes
and have been associated with congenital Zika syndrome in
fetuses and severe hemorrhagic fever, respectively (Hamel et al.,
2015). Beginning in December 2013, the Pan American Health
Organization (PAHO) and World Health Organization (WHO)
have classified CHIKV, DENV, and ZIKV as emerging public
health problems in the Americas. The WHO estimates that
DENV is endemic in 100 countries and 50–100 million DENV
infections occur yearly1. These numbers could be underestimates
due to unreported and misclassified cases. To date ZIKV
outbreaks and viral transmission have been identified in 86
countries in four continents2 while CHIKV outbreaks have
been identified in more than 40 countries in the Americas
(Morrison, 2014).
During natural transmission, alphaviruses and flaviviruses
are introduced into the skin through bites by infected
mosquitos. Due to their presence in the anatomical site of
initial infection, dermal dendritic cells (DCs) are among the
first cells to encounter incoming viruses (Klimstra et al.,
2003). DCs specifically express on their surface DC-specific
intercellular adhesion molecule 3-grabbing non-integrin (DC-
SIGN), a C-type (calcium-dependent) lectin specialized for the
capture and presentation of foreign antigens (Soilleux, 2003;
Koppel et al., 2005). As a type II transmembrane protein, DC-
SIGN contains extracellular, transmembrane, and intracellular
domains, thereby allowing the protein to perform important
functions in cell adhesion, pathogen recognition, and signaling
(Zhang et al., 2014; Mayer et al., 2017). Both alphaviruses and
flaviviruses infect cells by binding to plasma membrane (PM)
receptors, endocytic uptake, and low pH-triggered fusion in the
endosomal compartment (Kuhn, 2013; Pierson, 2013). Previous
publications have demonstrated the importance of interaction
with DC-SIGN during the alphavirus and flavivirus attachment
and internalization steps (Navarro-Sanchez et al., 2003; Barba-
spaeth et al., 2005; Froelich et al., 2011; Long et al., 2013). These
studies highlight the importance of further characterizing the role
of DC-SIGN during virus internalization and its potential as a
target for novel antiviral therapy.
Surface layer (S-layer) proteins are found in the outermost
cell envelope of numerous members of the Archaea and Bacteria,
including many species of the genus Lactobacillus comprising
major bacterial species found in human intestines (Hynönen
and Palva, 2013). S-layer proteins are organized into arrays of
a single polypeptide non-covalently bound to the bacterial cell
surface. They are considered to function as protective coats, in
the maintenance of cell shape, in ion exchange in the cell wall,
1https://www.cdc.gov/dengue/epidemiology/index.html
2https://www.who.int/en/news-room/fact-sheets/detail/zika-virus
and in adhesion to biotic and abiotic surfaces. We and others have
shown that the interaction between the S-layer of Lactobacillus
acidophilus, one of the major bacterial species found in human
intestines, and DC-SIGN can act as a potent inhibitor of JUNV
and H9N2 viral infections (Martínez et al., 2012; Gao et al., 2016;
Prado Acosta et al., 2016). Given that L. acidophilus and S-layer
are both categorized as “generally recognized as safe” (GRAS)
(Dunne et al., 2001; Mohamadzadeh et al., 2008), there is interest
in further characterizing this novel mechanism of inhibition in
order to develop new therapeutics that would target alphaviruses
and flaviviruses.
In this work, we assayed for an S-layer protective effect in
alphavirus and flavivirus infection of DC-SIGN-expressing cells.
The alphavirus Semliki Forest Virus (SFV) was then used as a
tool to investigate the antiviral mechanism of S-layer in DC-
SIGN-expressing vs. control cells. We describe the unexpected
binding of S-layer to cells devoid of DC-SIGN but also confirm
that the presence of DC-SIGN was essential for S-layer’s antiviral
activity. S-layer protein exerted its antiviral effect with different
kinetics than mannan, a known viral inhibitor that also acts on
DC-SIGN (Yu et al., 2017). Together our results suggest that
inhibition of viral entry by S-layer occurs via a novel S-layer/DC-
SIGN interaction.
MATERIALS AND METHODS
Isolation of S-Layer Proteins
S-layer proteins were extracted from overnight cultures of
L. acidophilus ATCC 4356 cells grown in MRS medium at
37◦C by using 6 M LiCl. The protein was extensively dialyzed
against distilled water overnight at 4◦C and after centrifugation
(10,000× g 20 min), it was suspended in sterile H2O and stored at
20◦C (Beveridge et al., 1997). Purity was evaluated by SDS-PAGE,
which showed a single band after Coomassie blue staining.
Cell Lines and Viruses
Vero cells, 3T3 cells, and 3T3 cells stably expressing human
DC-SIGN (3T3 DC-SIGN) were cultured at 37◦C in Dulbecco’s
modified Eagle’s medium containing 10% fetal bovine serum,
100 U penicillin/ml, and 100 µg streptomycin/ml. 3T3 parental
and 3T3 DC-SIGN-expressing cells were a kind gift from Vineet
N. Kewal Ramani, HIV Drug Resistance Program, NCI. SFV was
a well-characterized plaque-purified isolate (Glomb-Reinmund
and Kielian, 1998), CHIKV was the vaccine strain 181/25,
obtained from Dr. Robert Tesh (University of Texas Medical
Branch at Galveston, Galveston, TX, United States), DENV 2
(DENV-2) was strain 16681, and ZIKV was strain IbH obtained
from the NIH BEI program. All alphavirus stocks were obtained
by propagation in BHK-21 cells while the flaviviruses ZIKV and
DENV were propagated in C6/36 mosquito cells.
Antibodies and Reagents
A rabbit polyclonal antibody raised against the SFV envelope
proteins (Ahn et al., 1999) and cross reacting with the
CHIKV envelope proteins was used for immunofluorescence
experiments (anti-SFV Ab). Rabbit anti-human DC-SIGN
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(D7F5C) antibodies were purchased from Cell Signaling
Technologies. The rabbit polyclonal antibody against S-layer
was produced as previously published (Acosta et al., 2008).
Mannan from Saccharomyces cerevisiae was obtained from Sigma
(M7504). Alexa 568-conjugated phalloidin and Alexa 488-, 561-,
or 405-conjugated anti-mouse or anti-rabbit antibodies were
obtained from Molecular Probes.
Production of the CLR-Fc Fusion Protein
The cDNA encoding the extracellular part of DC-SIGN
was amplified by polymerase chain reaction (PCR) and
was then ligated into the pFuse-hIgG1-Fc (primers:
FW-5′-GAATTCGTCCAAGGTCCCCAGCTCCAT-3′; RV-
5′-CCATGGACGCAGGAGGGGGGTTTGGGGT-3′). CHO-S
cells were transiently transfected with the construct using MAX
reagent (InvivoGen). CLR–hFc fusion proteins were purified
after 4 days of transfection from the cell supernatant using
HiTrap protein G HP columns (GE Healthcare, Piscataway, NJ,
United States). To confirm its purity, the fusion protein was
analyzed by SDS-PAGE and subsequent Coomassie staining
and by Western blot using an anti-human IgG-horseradish
peroxidase (HRP) antibody.
ELISA-Based Binding Studies
A special microplate with half-area wells (Greiner Bio-One
GmbH, Frickenhausen, Germany) was coated with 50 µl
of 1 µg/ml of S-layer protein ON at RT. Non-adherent
protein were washed away, and the plate was blocked with
buffer containing 1% BSA (Thermo Fisher Scientific/Invitrogen,
Darmstadt, Germany) in 1x PBS for 2 h at RT. After washing the
wells, 50 µl containing 200 ng of each DC-SIGN, L-SIGN–hFc
fusion protein in lectin-binding buffer (50 mM HEPES, 5 mM
MgCl2, and 5 mM CaCl2) was added and incubated for 1 h at RT.
Then, a 1:5.000-diluted HRP-conjugated goat anti-human IgG
antibody (Dianova) was added for 1 h at RT. Finally, the substrate
solution [o-phenylenediamine dihydrochloride substrate tablet
(Thermo Fisher Scientific), 24 mM citrate buffer, 0.04% H2O2,
50 mM phosphate buffer in H2O] was added to the samples, and
the reaction was stopped with 2.0 M sulfuric acid. Data were
collected using a Multiskan Go microplate spectrophotometer
(Thermo Fisher Scientific) at a wavelength of 495 nm. When
competition assays were performed, different concentration
of S-layer were incubated with DC-SIGN-hFC protein and
subsequently incubated with a precoated plate with Mannan-
at 50 µg/ml.
Cell Viability Assays
Viability of cell cultures under each treatment condition was
determined by the MTT assay (Chacon et al., 1997). Briefly,
after 24 h of treatment with concentrations ranging from
50 to 400 µg/ml of S-layer, cell cultures were incubated
for 2 h in culture medium containing 0.5 mg ml-1 MTT.
After 2 h, the incubation buffer is removed and the blue
MTT–formazan product is extracted with acidified isopropyl
alcohol (0.04 N HCl). After 30 min extraction at room
temperature, the absorbance of the formazan solution is read
spectrophotometrically at 570 nm.
Virus Infection and Inhibition
Experiments
Monolayers of 3T3 parental, 3T3 DC-SIGN, or Vero cells were
cultured in 24-well plates and treated for 60 min at 37◦C with
different concentrations of S-layer, mannan at 50 µg/ml, or
medium as a control. Cells were then infected in the presence
of S-layer or mannan with SFV at multiplicity of infection
(MOI) = 10, CHIKV at MOI = 5, DENV-2 at MOI = 10, or ZIKV
at MOI = 10. After 3 h at 37◦C, cells were washed and incubated
with fresh media in the presence of 20 mM NH4Cl to prevent
secondary infection. Cells were fixed with 4% paraformaldehyde
(PFA, Electron Microscopy Science) at 24 h post infection (hpi)
for the alphaviruses SFV and CHIKV or 48 hpi for the flaviviruses
DENV-2 and ZIKV. Cells were permeabilized with 0.2% Triton
X-100 for 5 min at room temperature and then stained with
antibodies to detect the viral glycoproteins or with Hoechst 33342
(Invitrogen H3570) to visualize cell nuclei. Images were acquired
with a Zeiss inverted epifluorescence microscope, and a total of
30 fields of view were randomly acquired in three independent
experiments. The total number of cells was quantitated based
on the nuclei staining and infected cells were quantitated by
their positive expression of the viral antigen. The percentage of
infected cells relative to control untreated cells was determined.
Statistical significance was calculated by a two-tailed unpaired
Student’s t-test, as indicated in the figures.
Adsorption/Internalization Assay
3T3 wild type cells, 3T3 DC-SIGN-expressing cells, and Vero cells
were cultured in MatTek glass-bottom culture dishes (number
1.5; P35G-1.5-14-C; MatTek Corporation). Cells were either
untreated or incubated with 200 µg/ml S-layer for 1 h at 37◦C.
SFV (1× 109 pfu) in Rmed (RPMI without bicarbonate plus 0.2%
BSA and 10 mM HEPES) was bound to the cells for 60 min on
ice. The cells were then incubated at 37◦C in Rmed for 20 min to
permit endocytosis, washed on ice three times with PBS, and fixed
with 4% PFA for 20 min at room temperature. Cell surface virus
was stained with anti-SFV MAb and goat anti-rabbit Ig Alexa
Fluor 488 (Green). To visualize internalized virus, cells were then
permeabilized with 0.2% Triton X-100 and intracellular virus was
stained with anti-SFV Ab and goat anti-rabbit Alexa Fluor 568
(Red). As a result, virus that remains bound to the cell surface
without internalization will be stained in yellow/green color while
virus that was internalized and thus no longer on the cell surface
will only be colored in red. S-layer was detected by S-layer Ab
and goat anti-mouse Ig Alexa Fluor 405 (Blue). The samples were
analyzed by confocal microscopy and images were captured using
a Zeiss Live DuoScan confocal microscope.
DC-SIGN Endocytosis Assay
DC-SIGN-expressing 3T3 cells were treated with S-layer
(200 µg/ml) or media alone for 60 min at 37◦C. Cells were then
incubated with a rabbit anti DC-SIGN antibody for 15 min at
4◦C then fixed and stained with anti-rabbit secondary antibodies
Alexa Fluor 488. Other cells were further incubated at 37◦C for
30 min, fixed, permeabilized, and stained with an Alexa Fluor 568
secondary antibody. Cells were imaged by confocal microscopy.
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Flow Cytometry
3T3, 3T3 DC-SIGN, or Vero cells were plated in 10 cm
dishes and the next day dissociated from the dish using
Accutase (Sigma–Aldrich A6964) treatment at 37◦C. Cells were
resuspended, counted, and aliquoted into an untreated 96-well
U-bottom plate. The cells were washed twice in MEM media with
2% FBS, or for cells to be treated with EGTA, washed twice in
calcium-deficient MEM without FBS (since it contains calcium).
Cells were resuspended in the relevant MEM± 10 mM EGTA and
incubated at 37◦C for 30 min to allow for chelation of calcium
from surface proteins. Cells were then washed again in the
relevant MEM and resuspended in MEM containing S-layer at
the concentrations indicated in the legend. Cells were incubated
with S-layer for 60 min at 37◦C, washed once in PBS, and fixed
for 10 min at room temperature with 4% PFA. Following fixation,
cells were washed in FACS wash buffer (PBS with 2% BSA and
20 mM EDTA) and then incubated with primary antibody (rabbit
anti-S-layer) at 1:1500 for 45 min. Cells were washed twice in
FACS wash buffer, and then resuspended in secondary antibody
(Life Technologies A11008 goat anti-rabbit-488) at 1:1000 and
incubated for 30 min at room temperature. Cells were washed
twice, and fluorescent signal was measured by flow cytometry
using a BD LSR II Flow Cytometer. Cytometry data were analyzed
using FlowJo software.
RESULTS
S-Layer Protein From L. acidophilus
Blocks Virus Infection in a
DC-SIGN-Dependent Manner
We used the well-described 3T3 DC-SIGN model (Wu et al.,
2002) to evaluate the effect of S-layer on alphavirus and flavivirus
infection. In parental 3T3 cells (which do not express DC-
SIGN), infection by the alphaviruses SFV or CHIKV, or the
flaviviruses DENV-2 or ZIKV was very low or not detected
(Figure 1A). When human DC-SIGN was expressed in these
cells, both alphaviruses and flaviviruses efficiently infected
the cells (Figure 1A). 3T3 DC-SIGN cells were treated with
increasing concentrations of purified S-layer for 60 min prior
to and during infection. S-layer inhibited both alphavirus and
flavivirus infection in a dose-dependent manner (Figures 1B,C).
As predicted, mannan also inhibited infection due to its known
block of virus binding to DC-SIGN (Figures 1B,C). To verify
FIGURE 1 | S-layer protein from L. acidophilus blocks virus infection in a DC-SIGN-dependent manner. (A) Parental 3T3 or 3T3 DC-SIGN cells were infected with
the alphaviruses SFV or CHIKV and the flaviviruses DENV-2 or ZIKA. (B–D) Cells were preincubated for 60 min at 37◦C with the indicated concentrations of S-layer
protein or with 50 µg mannan/ml as a control. Cells were then infected with the indicated viruses for 3 h in the continuous presence of S-layer or mannan. (B) 3T3
DC-SIGN cells were infected with the alphaviruses SFV or CHIKV. (C) 3T3 DC-SIGN cells were infected with the flaviviruses DENV-2 or ZIKA. (D) Vero cells were
infected with SFV. For the samples in A–D, after 3 h infection at 37◦C, the cells were transferred to media containing 20 mM NH4Cl to prevent secondary infection.
Cells were fixed at 24 hpi for alphaviruses (A,B,D) or 48 hpi for flaviviruses (A,C), and infection scored by immunofluorescence. Graphs show the percentage of
infection normalized to 3T3 DC-SIGN or Vero cells in the absence of treatment. (E) Cell viability was determined by MTT assay after a 24 h treatment. Cytotoxicity
effect of the protein S-layer protein in 3T3 DC-SIGN cells was studied, and no toxicity was found in the range of S-layer concentrations needed for virus inhibition. All
graphs represent the mean and standard deviation of three independent experiments. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.
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that the inhibitory effect of S-layer in SFV infection on 3T3
DC-SIGN cells was due to the interaction between S-layer and
DC-SIGN, we also tested Vero cells, which are permissive to
viral infection but do not express DC-SIGN (Phanthanawiboon
et al., 2014). S-layer treatment of Vero cells produced no effect
on SFV infectivity, indicating that the antiviral mechanism
of S-layer is DC-SIGN dependent (Figure 1D). Cytotoxicity
effect of the protein S-layer protein in 3T3-DC-SIGN cells
was determined by MTT assay. As shown in previous studies
(Martínez et al., 2012) and as expected by our microscopy
observations, no toxicity was caused by the concentrations of
S-layer used in this study (IC50 = 147.79 µg/ml) (Figure 1E).
Taken together, our data indicate that S-layer protein can
specifically block DC-SIGN-dependent infection of alphaviruses
and flaviviruses.
S-layer could potentially cause antiviral effects by inhibiting
DC-SIGN-mediated internalization or by acting directly on the
viral particle. To address the possibility that S-layer is affecting
viral particle stability or fusion activity, we pre-treated SFV
for 60 min with increasing concentrations of S-layer, or with
mannan as a control. We then removed S-layer protein by
taking advantage of its limited solubility in physiologic salt
solution (Hynönen and Palva, 2013). S-layer protein was pelleted
by low speed centrifugation (10,000 × g 20 min) and the
treated or control virus was tested for infectivity on 3T3 DC-
SIGN cells (Figure 2A) or Vero cells as a non-DC-SIGN-
expressing control (Figure 2B). Pretreatment with S-layer did
not affect SFV infectivity in the presence or absence of DC-
SIGN. In contrast, mannan, a highly soluble compound that is
not separated from the virus by low speed centrifugation, blocked
virus infection of DC-SIGN-expressing cells while showing no
FIGURE 2 | S-layer protein does not directly affect SFV infectivity. SFV was
incubated with increasing concentrations of S-layer or mannan for 60 min at
37◦C. S-layer protein was then removed from the virus by low speed
centrifugation, while mannan remained in the virus mixture after centrifugation.
Treated or control virus was then incubated with (A) 3T3 DC-SIGN cells or (B)
Vero cells. After 3 h at 37◦C, the virus inoculum was replaced with media
containing 20 mM NH4Cl to prevent secondary infection. Cells were cultured
for a total of 24 hpi and infection scored by immunofluorescence. Graphs
show the percentage of infection normalized to the untreated controls, and
represent the mean and standard deviation of three independent experiments.
∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.
effect on infection of DC-SIGN-negative Vero cells. Thus, there
was no direct effect on the SFV viral particle of either S-layer
protein or mannan.
S-Layer Protein Binds Directly but Not
Exclusively to DC-SIGN
Direct binding of S-layer to DC-SIGN was evaluated by an
ELISA assay. This method is based on the expression of a
DC-SIGN-hFc fusion protein in which the extracellular part
of human DC-SIGN has been fused to the Fc fragment of
human IgG1 molecule (Mayer et al., 2018). The S-layer protein
was immobilized on the ELISA plate, incubated with the
respective DC-SIGN-hFc fusion proteins, and their interaction
was quantitated by colorimetric detection (Figure 3A). As
expected, a direct interaction was observed by this binding assay
(Konstantinov et al., 2008; Lightfoot et al., 2015; Gao et al., 2016).
We determined the calcium dependence of the DC-SIGN/S-
layer interaction, incubating the proteins in the presence of
EGTA. As predicted, the interaction was completely blocked in
the presence of EGTA demonstrating its calcium dependency
(Figure 3A). Furthermore, we performed competition assays
by immobilizing mannan on the ELISA plate and then
evaluating the interaction of mannan with DC-SIGN-hFc in
the presence of different concentrations of S-layer protein. We
observed decreased mannan-DC-sign interaction as the S-layer
concentration increased, thus showing a clear competition of
mannan and S-layer for binding to DC-SIGN (Figure 3B).
We then evaluated the binding of S-layer to DC-SIGN at
the PM by performing confocal microscopy studies. 3T3, 3T3
DC-SIGN, and Vero cells were treated with S-layer protein for
60 min at 37◦C, washed extensively, and then immunostained in
the absence of permeabilization to detect surface S-layer protein.
Phalloidin was used to label actin to delineate cell boundaries,
allowing us to cleanly define cell-associated S-layer. As expected,
we found that S-layer binds to DC-SIGN-expressing 3T3 cells
(Figure 3C). Unexpectedly, S-layer also bound to the surface of
the DC-SIGN negative 3T3 and Vero cells. Thus, S-layer binding
was observed even in the absence of DC-SIGN, but S-layer only
inhibited virus infection in cells expressing DC-SIGN (Figure 1).
These results challenge the idea that the S-layer mechanism of
action is due to direct blocking of virus absorption to DC-SIGN.
To have a quantitative comparison of the level of S-layer
binding across the three cell types used in our experiments,
we used flow cytometry to measure S-layer binding to non-
permeabilized uninfected Vero, 3T3, and 3T3 DC-SIGN cells.
We found that there were not large differences in S-layer
binding across the three cell types, despite the lack of DC-
SIGN expression in Vero and 3T3 cells (Figure 3D). At 24 µg
S-layer/ml, 98% of Vero cells stained positive for S-layer while
83 and 84% of 3T3 and 3T3 DC-SIGN cells, respectively, were
positive at this concentration. At a lower concentration of S-layer
(6 µg/ml), differences in the percentage of cells bound by S-layer
were more pronounced, but the presence of DC-SIGN did not
account for the difference in binding since the percentage of
Vero cells bound by S-layer was the highest (88%) and 3T3
and 3T3 DC-SIGN cells were approximately equivalent (50 and
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FIGURE 3 | S-layer protein binding to DC-SIGN and to cells. (A) ELISA binding assays to S-layer coated plate. The DC-SIGN h-FC fusion protein was diluted in lectin
binding buffer or EGTA buffer, incubated with S-layer-coated plates, and washed after incubation to eliminate non-bound protein. Controls were performed using
h-FC alone. Unbound proteins were removed by washing and levels of DC-SIGN fusion protein bound to the plate were measured. ∗∗∗P < 0.001. (B) Competition
assays using a mannan-coated plate. DC-SIGN-hFc fusion proteins were added to the plate along with increasing concentrations of S-layer. Unbound proteins were
(Continued)
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FIGURE 3 | Continued
removed by washing and levels of DC-SIGN fusion protein bound to the plate were measured. (C) 3T3 DC-SIGN, parental 3T3, and Vero cells were incubated with
200 µg/ml of S-layer for 1 h at 37◦C. Cells were washed, fixed, and stained with antibodies to detect DC-SIGN (green) and S-layer (blue), and with phalloidin (red) to
detect F-actin. Cells were imaged by confocal microscopy. Panel shows confocal extended focus images representative of three independent experiments.
Bar = 20 µM. (D) Parental 3T3, 3T3 DC-SIGN, and Vero cells were either untreated or treated with 10 mM EGTA, and then incubated 60 min at 37◦C with 6, 12, or
24 µg S-layer/ml in the presence or absence of EGTA. Binding was detected by an anti-S-layer antibody and measured using flow cytometry. Data are expressed as
percentage of positive cells vs. cells not incubated with S-layer but antibody stained in parallel. The data shown are representative of four independent experiments.
59%, respectively). We also analyzed the median fluorescence
intensity (MFI) of each cell type as a ratio of the signal obtained
with 24 µg S-layer/ml vs. the background staining of no S-layer
controls (Supplementary Figure S1). Vero cells demonstrated
the highest level of binding (83.7 MFI), followed by 3T3 DC-
SIGN (17.5 MFI), and lastly 3T3 cells (12.8 MFI). Together these
results indicate that binding of S-layer is not restricted to DC-
SIGN and suggest that it can bind to additional surface molecules.
To further investigate the role of DC-SIGN in S-layer binding,
we tested if calcium chelation with EGTA, a treatment shown
to change the structure of DC-SIGN and other C-type lectins
(Zhang et al., 2014), would have an effect on S-layer binding.
We found that EGTA treatment decreased the percentage of cells
bound by S-layer for all cell types but did not eliminate binding
(Figure 3D). Treatment with EGTA during binding of 24 µg
S-layer/ml decreased the MFI of Vero cells by ∼50%, and the
MFI of 3T3 and 3T3 DC-SIGN cells by 82 and 74%, respectively.
Together, our results suggest that even though S-layer does binds
directly to DC-SIGN, as shown by the ELISA, it is not the only
surface molecule mediating S-layer binding.
S-Layer Decreases Virus Adsorption and
Internalization in a DC-SIGN-
Dependent Manner
While we observed binding of the S-layer protein to cells
independent of DC-SIGN expression, we only detected a
protective effect against infection in cells expressing DC-SIGN.
To further understand the mechanism of such protection, we
performed assays to dissect the effect of S-layer on virus
adsorption and/or internalization. Cells were incubated with
SFV for 60 min at 4◦C to allow virus adsorption and then
incubated 20 min at 37◦C to promote virus internalization. Cells
were fixed and immunofluorescence staining was performed to
detect cell surface adsorbed, but not internalized viruses in the
green channel. We then permeabilized the cells and a second
immunofluorescence-staining step was performed to detect both
adsorbed and internalized virions in the red channel. Note that
internalized virus will uniquely stain red in this assay and will
be visualized as intracellular puncta, while viruses bound to
the PM and not internalized will be stain in a green/yellow
(green+red) color. In 3T3 cells that do not express DC-SIGN,
S-layer was observed bound to the membrane, as were the
viral particles. However, in the absence of DC-SIGN, few viral
particles were internalized in 3T3 parental cells either with or
without S-layer treatment (Figure 4A). As expected, in 3T3 DC-
SIGN cells in the absence of S-layer treatment, viral particles
were efficiently adsorbed and internalized (Figure 4B). Both
adsorption and internalization were markedly reduced when
FIGURE 4 | S-layer protein blocks virus internalization in a
DC-SIGN-dependent manner. (A) Parental 3T3, (B) 3T3 DC-SIGN, and
(C) Vero cells were pretreated for 60 min at 37◦C with control media or media
containing 200 µg S-layer/ml. Cells were then incubated with SFV for 60 min
at 4◦C and then shifted to 37◦C for 20 min to permit endocytosis, all in the
continuous absence or presence of S-layer. Cells were fixed and stained with
antibody to the envelope proteins before and after cell permeabilization. These
conditions detect virus present at the cell surface in both green/yellow while
internalized viruses will only present a red staining. S-layer protein was only
detected at the surface and is labeled in blue. Cells were imaged by confocal
microscopy. Images from one optical section are shown and are
representative of three independent experiments. Magnification of all images is
the same, with the bar in the upper right hand panel representing 20 µM.
S-layer treatment was performed. As a control for the effect
of S-layer in a permissive cell line that does not express DC-
SIGN, we performed similar assays in Vero cells. In agreement
with the results in Figure 2, S-layer efficiently bound Vero
cells but failed to inhibit viral adsorption and internalization
(Figure 4C). These data thus are in keeping with a role for
S-layer/DC-SIGN interaction in triggering protection against
viral infection.
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FIGURE 5 | S-layer protein binding does not block DC-SIGN antibody binding
or internalization. 3T3 DC-SIGN cells were pretreated with 200 µg S-layer/ml
or control media for 60 min at 37◦C. Cells were then incubated with
anti-DC-SIGN antibody for 15 min at 4◦C and (A) immediately fixed or (B)
further incubated for 30 min at 37◦C to allow antibody-DC-SIGN complex
internalization, and then fixed. Cells were then stained using conditions that
detect DC-SIGN antibody on the cell surface (green/yellow) vs. internalized
DC-SIGN antibody (red), and with antibodies to detect S-layer (blue). Cells
were imaged by confocal microscopy. Images from one optical section are
shown and are representative of two independent experiments. Magnification
of all images is the same, with the bar in the upper right hand panel
representing 20 µM.
S-Layer Protein Does Not Change
DC-SIGN Localization or Internalization
Our results suggested that S-layer interaction with DC-
SIGN was essential to block virus binding/internalization.
A possible explanation could be that S-layer directly or
indirectly affects DC-SIGN expression at the PM or its
endocytosis/intracellular trafficking. To study the effect of S-layer
on DC-SIGN membrane localization and internalization, we
performed adsorption/internalization assays using an anti-DC-
SIGN antibody. 3T3 DC-SIGN cells were pretreated with control
or S-layer-containing-media for 60 min at 37◦C. The cells were
then either incubated with the anti-DC-SIGN antibody for
15 min at 4◦C and fixed (Figure 5A), or further incubated at
37◦C to allow internalization of the antibody/DC-SIGN complex
(Figure 5B). Figure 5A shows that DC-SIGN was present at the
PM of both control and S-layer treated cells. The distribution
pattern of DC-SIGN at the PM was unchanged by S-layer
treatment. Incubation at 37◦C to allow uptake of the DC-SIGN
antibody showed that S-layer pretreatment did not block DC-
SIGN internalization (Figure 5B). Thus, S-layer did not disrupt
DC-SIGN PM localization or its internalization, suggesting that
another mechanism is responsible for the antiviral effect of
S-layer on DC-SIGN-expressing cells.
FIGURE 6 | S-layer protein blocks virus binding, internalization and infection in
a time-dependent manner. (A) 3T3 DC-SIGN cells were pre-incubated at
37◦C with the indicated concentrations of S-layer or with mannan (50 µg/ml)
for 0, 10, 30, or 60 min, or with control media for 60 min. Cells were then
infected with SFV for 3 h at 37◦C in the continuous presence S-layer or
mannan, where 0 min indicates addition simultaneous with virus. After 3 h at
37◦C, media were replaced with media with NH4Cl to prevent secondary
infection. Cells were cultured for 24 hpi and infection scored by
immunofluorescence. Graphs show the percentage of infection normalized to
the untreated controls, and represent the mean and standard deviation of
three independent experiments. ∗∗P < 0.01. (B) 3T3 DC-SIGN cells were
treated at 37◦C with 200 µg S-layer/ml for 0, 10, 30, or 60 min, or with control
media for 60 min. Cells were then incubated with SFV for 60 min at 4◦C and
transferred to 37◦C for 25 min to permit endocytosis in the continuous
presence or absence of S-layer. Cells were fixed and stained with antibody to
the envelope proteins before and after cell permeabilization, using conditions
that detect virus remaining on the cell surface (green/yellow) vs. internalized
virus (red), and with antibodies to detect S-layer (blue). Cells were imaged by
confocal microscopy. Images from one optical section/sample are shown and
are representative of three independent experiments. Bar = 20 µM.
S-Layer Protein Blocks Alphavirus
Infection in a Time-Dependent Manner
In an effort to further explore the mechanism of inhibition
for S-layer, we decided to compare its antiviral activity to that
of the well-characterized DC-SIGN ligand mannan. Mannan is
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a glycan that is known to directly bind DC-SIGN and block
viral particles from engaging the protein, thereby preventing
pathogen internalization (Shimojima and Takenouchi, 2014).
One potential difference in the mechanism is the kinetics with
which each inhibitor operates. Mannan blocks virus infection
immediately by sterically preventing virus binding to DC-SIGN,
while the time course of the antiviral effects of S-layer was
unknown. To determine this, we pretreated cells with S-layer,
mannan, or control media for the indicated times at 37◦C, then
incubated them with SFV for 3 h, and quantitated primary
infection (Figure 6A). While inhibition by mannan was observed
immediately upon addition (time 0), the protective effect of
S-layer was apparent only after 30 or 60 min of pretreatment.
Virus adsorption and internalization were also examined by
microscopy (Figure 6B). While S-layer association with the cells
was observed after all times of addition, S-layer effect on virus
adsorption and internalization was stronger after 30 or 60 min
of pretreatment. These data suggest that even though S-layer and
mannan both act on DC-SIGN at the PM, their mechanisms of
action are different.
DISCUSSION
The incidence of mosquito-borne diseases, including those
caused by alphaviruses and flaviviruses, has increased
dramatically in recent years. Not only is the range of some
mosquitoes expanding to new areas, but some viruses are
also adapting to use new species of host mosquitoes (Weaver
and Barrett, 2004; Morrison, 2014). Unfortunately, there are
currently no available treatments for alphavirus or flavivirus
infections, and new therapies or preventative measures are
urgently needed. In the present work, we investigated
the inhibitory effect of the L. acidophilus-derived S-layer
protein in alphavirus and flavivirus infection. The goals of
this work were to gain new understanding of the inhibitory
mechanism of S-layer on viral infection and to potentially
identify new antiviral targets in the viral entry process. The
well-characterized alphavirus SFV provided an excellent
model to dissect the mechanism by which S-layer protein
blocks infection.
We confirmed that DC-SIGN plays a role in the infection
pathway of alphaviruses and flaviviruses by demonstrating
that expression of human DC-SIGN on 3T3 cells strongly
promoted infection. However, DC-SIGN was not required for
infection of all cell types: SFV efficiently infected Vero cells,
which do not express DC-SIGN. S-layer treatment of 3T3
DC-SIGN cells prevented infection by SFV, CHIKV, DENV-
2, and ZIKV. In contrast, treatment of Vero cells with
S-layer had no effect on SFV infection, indicating that the
antiviral activity of S-layer requires the presence of DC-SIGN
(Figure 7). We ruled out the possibility that S-layer was
having a direct irreversible effect on the SFV viral particle
by showing that pre-incubation of the virus with S-layer did
not affect infectivity. Additionally, we determined that S-layer
treatment did not alter DC-SIGN surface expression or inhibit its
internalization. Experiments performed in previous publications
FIGURE 7 | Schematic of the effects of S-layer on alphavirus infection in
different cell lines. (A) Parental 3T3 cells do not support efficient alphavirus
uptake or infection, but virus was detected attached to the plasma membrane.
S-layer bound to the cell membrane but did not inhibit virus binding. (B) 3T3
DC-SIGN cells are permissive to virus infection, and infection is blocked by
S-layer. Treatment with S-layer strongly inhibits virus attachment to the plasma
membrane and also inhibits endocytic entry. Unbound viral particles are
washed away and thus are not represented in this scheme. (C) Vero cells are
permissive to infection but do not express DC-SIGN. While Vero cells can bind
S-layer, it causes no inhibition of virus binding, endocytic uptake, or infection.
and in this scoop demonstrated that S-layer does not affect
cell viability (Martínez et al., 2012). Therefore, the remaining
potential mechanisms likely require an interaction between
S-layer and DC-SIGN.
The direct binding between DC-SIGN and S-layer was
demonstrated by an ELISA binding assay, and this direct
interaction was previously observed by other groups using
different methodologies (Konstantinov et al., 2008; Mobili
et al., 2009; Taverniti et al., 2013; Lightfoot et al., 2015;
Gao et al., 2016; Prado Acosta et al., 2016). Unexpectedly,
our immunofluorescence staining and flow cytometry results
indicated that S-layer does not require DC-SIGN for binding to
cell surface membranes. S-layer bound equally well to 3T3 and
Frontiers in Microbiology | www.frontiersin.org 9 April 2019 | Volume 10 | Article 810
fmicb-10-00810 April 15, 2019 Time: 15:56 # 10
Prado Acosta et al. S-Layer Blocks Viral Infection
3T3 DC-SIGN cells, and showed the highest binding to DC-
SIGN-negative Vero cells. Flow cytometry results also showed
that EGTA treatment did not completely eliminate S-layer
binding to any of the three cell types; however, EGTA did
completely block S-layer biding to DC-SIGN in the ELISA
binding assay. Thus, while S-layer can directly interact with DC-
SIGN, this does not preclude its binding to other cell surface
molecules. This is in keeping with previous evidence that S-layer
is capable of binding various cell surface and extracellular matrix
proteins, including fibronectin (Hymes et al., 2016).
We performed microscopy experiments to evaluate virus
binding and entry in the presence or absence of S-layer.
S-layer did not prevent virus binding or internalization in
3T3 parental cells or Vero cells, both of which were devoid
of DC-SIGN. While the 3T3 parental cells showed significant
binding and little endocytosis of virus, this pattern was not
detectably changed by S-layer treatment. In contrast, the 3T3
DC-SIGN cells efficiently bound and internalized SFV, and
treatment with S-layer reduced both virus adsorption and
internalization. The inhibition of virus-cell binding suggests
that the antiviral effect of S-layer could be at least in
part due to direct competition with virus particles for
binding to DC-SIGN (Figure 7). The reduction in viral
entry suggests the possibility that S-layer has additional
antiviral mechanism(s).
Mannan is a well-characterized DC-SIGN ligand and a known
inhibitor of virus-DC-SIGN binding (Yu et al., 2017). We
compared the time course of inhibition by mannan and S-layer
in 3T3 DC-SIGN cells. The effect of mannan on viral infection
was immediate, with full inhibition even when mannan was
added at the same time as the virus. In contrast, significant
inhibition by S-layer was only seen after 30 min of pretreatment.
There are several potential explanations for the difference in
the kinetics of these two DC-SIGN interacting molecules. One
could be that S-layer simply requires a longer time for its
inhibitory mode of binding to DC-SIGN. Such binding kinetics
may not be detected in our immunofluorescence assays. Another
explanation is that the DC-SIGN-S-layer interaction is triggering
signaling pathways that require time to achieve their antiviral
effect. In fact, there is ample evidence in the literature that
bacterially derived surface proteins, including S-layer, are capable
of triggering a variety of signaling pathways (Tytgat et al.,
2016). S-layer can induce production of the anti-inflammatory
cytokine IL-10 in immature DCs (Konstantinov et al., 2008),
while in macrophage cells, it induces production of TNF-alpha,
a pro-inflammatory cytokine (Taverniti et al., 2013). S-layer
is also known to be a ligand for TLR2 (Konstantinov et al.,
2008; Taverniti et al., 2013), and 3T3 cells are reported to
express TLR2 (Lin et al., 2000). Additionally, DC-SIGN is also
a mediator of signaling following the recognition of pathogen-
associated motifs (Geijtenbeek et al., 2009). Thus, it is possible
that S-layer binding to DC-SIGN triggers a time-dependent
signaling pathway that inhibits viral entry and infection. Further
studies will be necessary to define the mechanisms involved in
S-layer inhibition.
Given the evidence that S-layer prevents viral entry,
potentially through multiple mechanisms, S-layer proteins can be
considered for further investigation as a novel class of antivirals.
Recently L. acidophilus surface layer protein has been proposed
as a treatment for intestinal disorders in humans (Lightfoot
et al., 2015). Additionally, Gao et al. (2016) showed that S-layer
competes with avian influenza virus (H9N2) for binding to DC-
SIGN and inhibits virus infection of DCs. Thus, in addition
to the effect of S-layer on alphavirus and flavivirus infection,
there may be broader therapeutic possibilities for the use of
S-layer protein.
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